Results 111 to 120 of about 46,386 (217)

Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for Tuberculous Meningitis. [PDF]

J Infect Dis
Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, Singh M, Nino-Meza OJ, Peloquin CA, Artemov D, Jain SK.   +7 more
europepmc   +1 more source

Cost-effectiveness of latent tuberculosis infection screening using interferon-gamma release assays among migrants to Japan: a Markov modelling study incorporating social vulnerability and access barriers. [PDF]

BMJ Open
Kowada A.
europepmc   +1 more source

Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis. [PDF]

J Clin Tuberc Other Mycobact Dis
Alavandar A.
europepmc   +1 more source

DU‐Vigilance; Capturing Unsuspected Problems in Drug Utilization

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 8, August 2026.
Jesper Hallas, Hanin Harbi, Thomas Delvin, Lotte Rasmussen   +3 more
wiley   +1 more source

Preparation of a chloride salt of covalently modified isoniazid. [PDF]

Acta Crystallogr E Crystallogr Commun
Mahwasane R, Smith MG.
europepmc   +1 more source

Trends and determinants of isoniazid preventive therapy initiation in antiretroviral therapy-treated HIV-positive adults in Tanzania Mainland 2015-2020: a retrospective observational study using medical records. [PDF]

BMJ Open
Meela EB, Waria G, Shirima LJ, Mlay HL, Ngowi M, Maghembe AA, Meela J, Pallangyo DS, Balati J, Maokola W, Hugho E, Ngocho JS.   +11 more
europepmc   +1 more source

Registry‐Based Analysis of Treatment and Retreatment Attacks of Hereditary Angioedema

Clinical &Experimental Allergy, Volume 56, Issue 8, Page 986-988, August 2026.
Roman Hakl, Jan Baroš, Marta Sobotková, Radana Zachová, Pavlína Králíčková, Martina Vachová, Irena Krčmová, Michal Svoboda, Vendula Szmucová, Monika Skotáková, Jiří Litzman   +10 more
wiley   +1 more source

A Novel Therapy With a One-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB‑YOUTH Study): Protocol for a Cluster Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Yang Y, Zhou F, Ren Y, Li F, Yang Q, He Y, Wei X, Wang X, Luo J, Sun F, Shao L, Li J, Ruan Q, Zhang W.   +13 more
europepmc   +1 more source

Prevalence and profile of isoniazid mono-resistant tuberculosis in Pakistan: Insights from a decade of surveillance. [PDF]

Pak J Med Sci
Khursheed N, Zafar SM, Asif S, Adnan F.
europepmc   +1 more source

NAT2 rs1495741 and anti-tuberculosis drug-induced liver injury in children: genetic association and risk prediction. [PDF]

Front Pharmacol
Huang X, Jiang J, He L, Guo Y, Zhou J, Qiu H, Zhou H, Liu X, Yang H, Guo C.   +9 more
europepmc   +1 more source